B of A Securities Maintains Buy on Beta Bionics, Raises Price Target to $33

Benzinga · 5d ago
B of A Securities analyst Travis Steed maintains Beta Bionics (NASDAQ:BBNX) with a Buy and raises the price target from $30 to $33.